4.7 Article

Mind the Gap

期刊

ENVIRONMENTAL HEALTH PERSPECTIVES
卷 118, 期 12, 页码 1643-1645

出版社

US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
DOI: 10.1289/ehp.1002517

关键词

biomass smoke; cardiovascular disease; combustion particles; cookstoves; dose-response relationship; household air pollution; indoor air pollution; particulate matter; PM2.5

向作者/读者索取更多资源

BACKGROUND: Recent analysis has demonstrated a remarkably consistent, nonlinear relationship between estimated inhaled dose of combustion particles measured as PM2.5 (particulate matter with aerodynamic diameter <= 2.5 mu m) and cardiovascular disease mortality over several orders of magnitude of dose-from cigarette smoking, environmental tobacco smoke (ETS) exposure, and ambient air pollution exposure. OBJECTIVES: Here we discuss the implications of this relationship and point out the gaps in our knowledge that it reveals. DISCUSSION: The nonlinear exposure-response relationship that is revealed-much steeper at lower than at higher doses-explains the seemingly inconsistent risks observed from ambient air pollution and cigarette smoking but also raises important questions about the relative benefits of control at different points along the curve. This analysis also reveals a gap in the evidence base along the dose-response curve between ETS and active smoking, which is the dose range experienced by half the world's population from indoor biomass and coal burning for cooking and heating. CONCLUSIONS: The shape of the exposure-response relationship implies much larger public health benefits of reductions at the lower end of the dose spectrum (e. g., from reductions in outdoor air pollution) than from reducing the rate of active smoking, which seems counterintuitive and deserving of further study because of its importance for control policies. In addition, given the potential risks and consequent global disease burden, epidemiologic studies are urgently needed to quantify the cardiovascular risks of particulate matter exposures from indoor biomass burning in developing countries, which lie in the dose gap of current evidence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据